Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors
2 other identifiers
interventional
315
1 country
3
Brief Summary
The Sharing Our Strength study is being conducted to help us understand people's experiences with hematopoietic stem cell transplantation and to test a new program designed to help people recover physically and emotionally after transplant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable leukemia
Started Jul 2007
Typical duration for not_applicable leukemia
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2007
CompletedFirst Submitted
Initial submission to the registry
June 4, 2008
CompletedFirst Posted
Study publicly available on registry
June 19, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2011
CompletedNovember 17, 2017
May 1, 2013
4.2 years
June 4, 2008
November 14, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Psychological Adjustment
At screening, baseline and 3 months following intervention
Secondary Outcomes (1)
Quality of Life
At screening, baseline and 3 months following intervention
Study Arms (4)
Experimental Writing Type 1
EXPERIMENTALExperimental Writing type 2
EXPERIMENTALControl writing type 1
ACTIVE COMPARATORControl writing type 2
PLACEBO COMPARATORInterventions
Experimental informative writing
Experimental noninformative writing
Control noninformative writing
Eligibility Criteria
You may qualify if:
- Be a transplant survivor who is 9 months to 3 years beyond transplant and not currently relapsed. and not currently relapsed
- Be at least 18 years old now (and at least 16 when they had their transplant)
- Speak English
- Have telephone service
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Hackensack University Medical Center
Hackensack, New Jersey, 07601-1991, United States
Mount Sinai School of Medicine
New York, New York, 10029, United States
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599-6011, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christine Rini, Ph.D.
Icahn School of Medicine at Mount Sinai
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 4, 2008
First Posted
June 19, 2008
Study Start
July 1, 2007
Primary Completion
September 1, 2011
Study Completion
September 1, 2011
Last Updated
November 17, 2017
Record last verified: 2013-05